Home › NDC Lookup › RxCUI directory › RxCUI 1736590

Dexrazoxane 500 MG Injection — RxCUI 1736590

RxNorm drug concept · Semantic clinical drug
RxCUI 1736590 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1736590
Official nameDexrazoxane 500 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdexrazoxane (as dexrazoxane HCl) 500 MG Injection
FDA products mapped12
Package NDCs mapped12
Reported Medicaid activity (SDUD)265 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dexrazoxane Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Dexrazoxane is given to help protect your heart from damage caused by doxorubicin, the chemotherapy you're receiving. Doxorubicin is very effective against breast cancer, but over...
  • Why am I getting this medication along with my chemotherapy?
  • This is actually by design. Clinical research showed that starting dexrazoxane at the same time as your very first doxorubicin treatment can actually reduce how well the chemothera...
  • Why wasn't I given this from the very beginning of my chemo?
📖 Read our full Dexrazoxane Injection guide →

🕸️ Concept Web — How Dexrazoxane 500 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dexrazoxane 500 MG Injection RxCUI 1736590

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dexrazoxane 42736
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Totect 731011
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dexrazoxane Injection 1736584
    • Dexrazoxane Injectable Product 1154547
    • Dexrazoxane Injection [Totect] 1939306
    • Totect Injectable Product 1939307
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Dexrazoxane 500 MG 1736589
    • Dexrazoxane 500 MG Injection [Totect] 1939308
    • Dexrazoxane 500 MG [Totect] 1939305

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dexrazoxane 500 MG SCDC · 1736589
  • Dexrazoxane Injection SCDF · 1736584
  • Dexrazoxane Injectable Product SCDG · 1154547

Brand-Name Concepts

  • Dexrazoxane 500 MG Injection [Totect] SBD · 1939308
  • Dexrazoxane 500 MG [Totect] SBDC · 1939305
  • Dexrazoxane Injection [Totect] SBDF · 1939306
  • Totect Injectable Product SBDG · 1939307
  • Totect BN · 731011

📦 FDA Products & Package NDCs

12 products · 12 package NDCs
12 package NDCs map to RxCUI 1736590 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9247-01 1 VIAL in 1 BOX (0143-9247-01) / 1 INJECTION, POWDER, LYOPH... Dexrazoxane Hikma Pharmaceuticals USA Inc. 2017-10-05
00143-9248-01 1 VIAL in 1 BOX (0143-9248-01) / 1 INJECTION, POWDER, LYOPH... Dexrazoxane Hikma Pharmaceuticals USA Inc. 2017-10-05
55150-0434-01 1 KIT in 1 PACKAGE (55150-434-01) * 25 mL in 1 VIAL, SINGL... DEXRAZOXANE Eugia US LLC 2016-05-12
55150-0437-01 1 KIT in 1 PACKAGE (55150-437-01) * 50 mL in 1 VIAL, SINGL... DEXRAZOXANE Eugia US LLC 2016-05-12
68083-0195-01 1 VIAL in 1 CARTON (68083-195-01) / 50 mL in 1 VIAL Dexrazoxane Gland Pharma Limited 2016-12-05
68083-0388-01 1 VIAL in 1 CARTON (68083-388-01) / 25 mL in 1 VIAL Dexrazoxane Gland Pharma Limited 2019-12-16
72205-0247-01 1 VIAL, SINGLE-DOSE in 1 CARTON (72205-247-01) / 25 mL in 1... Dexrazoxane Novadoz Pharmaceuticals LLC 2025-04-09
72205-0248-01 1 VIAL, SINGLE-DOSE in 1 CARTON (72205-248-01) / 50 mL in 1... Dexrazoxane Novadoz Pharmaceuticals LLC 2025-04-09
72266-0101-01 1 VIAL in 1 CARTON (72266-101-01) / 50 mL in 1 VIAL Dexrazoxane Fosun Pharma USA Inc. 2019-03-18
72266-0235-01 1 VIAL in 1 CARTON (72266-235-01) / 25 mL in 1 VIAL Dexrazoxane Fosun Pharma USA Inc. 2021-11-01
72611-0716-01 1 VIAL, SINGLE-DOSE in 1 CARTON (72611-716-01) / 50 mL in 1... Dexrazoxane Almaject, Inc. 2020-09-01
72611-0716-72 1 VIAL, SINGLE-DOSE in 1 CARTON (72611-716-72) / 50 mL in 1... Dexrazoxane Almaject, Inc. 2022-06-01
Observed labelers: Almaject, Inc. (2) · Eugia US LLC (2) · Fosun Pharma USA Inc. (2) · Gland Pharma Limited (2) · Hikma Pharmaceuticals USA Inc. (2) · Novadoz Pharmaceuticals LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J1190 Dexrazoxane hcl injection 10 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.